Format

Send to

Choose Destination
Trends Cancer. 2016 Jan;2(1):49-63. doi: 10.1016/j.trecan.2015.11.003. Epub 2016 Jan 29.

Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine.

Author information

1
Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
2
Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Gastrointestinal Cancer Unit, The Royal Marsden Hospital, London, UK. Electronic address: marco.gerlinger@icr.ac.uk.

Abstract

The ability to predict the future behavior of an individual cancer is crucial for precision cancer medicine. The discovery of extensive intratumor heterogeneity and ongoing clonal adaptation in human tumors substantiated the notion of cancer as an evolutionary process. Random events are inherent in evolution and tumor spatial structures hinder the efficacy of selection, which is the only deterministic evolutionary force. This review outlines how the interaction of these stochastic and deterministic processes, which have been extensively studied in evolutionary biology, limits cancer predictability and develops evolutionary strategies to improve predictions. Understanding and advancing the cancer predictability horizon is crucial to improve precision medicine outcomes.

KEYWORDS:

cancer evolution; cancer genetics; drug resistance; precision cancer medicine; predictive biomarkers; prognostic biomarkers

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center